Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
These findings suggest that Mdm2 splice isoforms may play critical roles in the regulatory loop of p53 (show TP53 ELISA Kits)/Mdm2-Mdm4 (show MDM4 ELISA Kits) via a RING domain-mediated biochemical mechanism.
Tat (show TAT ELISA Kits) exploited the cellular HDM2 (human double minute 2 protein) ubiquitin ligase to accelerate IRF-1 (show IRF1 ELISA Kits) proteasome-mediated degradation, resulting in a quenching of IRF-1 (show IRF1 ELISA Kits) transcriptional activity during HIV-1 infection.
Data show that long noncoding RNAs lnc00462717 direct target MDM2 protein and regulate MAPK (show MAPK1 ELISA Kits) relevant pathway expression.
TLP (show TBPL1 ELISA Kits) Prevents p53 (show TP53 ELISA Kits) Degradation through Disrupting the p53 (show TP53 ELISA Kits)-MDM2 Interaction.
MDM2 T309G polymorphism is associated with risk and prognosis of lung cancer. TT or T genotype may be associated with the reduced risk of lung cancer, especially in Asians (Meta-Analysis)
NF2 (show NF2 ELISA Kits) regulates the interaction of FAK (show PTK2 ELISA Kits)-p53 (show TP53 ELISA Kits) and MDM2-p53 (show TP53 ELISA Kits).
Report up-regulation of TP53 (show TP53 ELISA Kits)/MDM2 signaling pathway in breast carcinomas.
Expressions of COX-2 (show COX2 ELISA Kits), p53 (show TP53 ELISA Kits), and MDM2 increased with oral submucous fibrosis progression.
LRRC8A (show LRRC8A ELISA Kits) is an essential regulator of cisplatin induced p53 (show TP53 ELISA Kits) protein activity and its downstream signaling involving increased expression of p21Waf1/Cip1 and MDM2, as well as activation of caspase-9 (show CASP9 ELISA Kits) and -3 in tumor cell lines.
These results indicate that p53 (show TP53 ELISA Kits)-independent upregulation of MDM2 by increasing selected clones may lead to oncogenesis.
both MDM2 and MDMX (show MDM4 ELISA Kits) deletion-caused pancreatic defects are completely rescued by loss of p53 (show TP53 ELISA Kits), verifying the crucial role of the MDM2 and/or MDMX (show MDM4 ELISA Kits) in regulating p53 (show TP53 ELISA Kits) in a spatio-temporal manner during the development, functional maintenance, and related disease progress of endocrine pancreas.
Vif (show BTG1 ELISA Kits) stabilization by CBFbeta (show CBFB ELISA Kits) is mainly caused by impairing MDM2-mediated degradation.
These results demonstrated a critical prosurvival role for MDM2 in the oocytes
we failed to detect any increase in p53 (show TP53 ELISA Kits) level in mutant oocytes, nor any other apoptotic marker, introgression of this targeted invalidation in p53 (show TP53 ELISA Kits)-/- mice restored the fertility of females. This study is the first to show that Mdm2, but not Mdm4 (show MDM4 ELISA Kits), has a critical role in oocyte survival and would be involved in premature ovarian insufficiency phenotype.
Inhibition of MDM2 re-sensitizes rapamycin resistant renal cancer cells via the activation of p53 (show TP53 ELISA Kits).
Inactivation of Mdm2 in sertoli cells triggers p53 (show TP53 ELISA Kits) activation and apoptosis as early as 15.5 days post conception with a significant increase in apoptosis.
These findings elucidate a critical role of Mdm2-p53-Nedd4-2 signaling underlying the regulation of neural network synchrony and seizure susceptibility.
These studies demonstrate that Mdm2 holds promise as a therapeutic target in combination with conventional therapy and may lead to new clinical therapies for Triple-negative breast cancers .
there is a fine tuned balance in the interaction of ribosomal proteins with the MDM2/p53 (show TP53 ELISA Kits) axis which is important in normal hematopoiesis.
This gene is a target gene of the transcription factor tumor protein p53. The encoded protein is a nuclear phosphoprotein that binds and inhibits transactivation by tumor protein p53, as part of an autoregulatory negative feedback loop. Overexpression of this gene can result in excessive inactivation of tumor protein p53, diminishing its tumor suppressor function. This protein has E3 ubiquitin ligase activity, which targets tumor protein p53 for proteasomal degradation. This protein also affects the cell cycle, apoptosis, and tumorigenesis through interactions with other proteins, including retinoblastoma 1 and ribosomal protein L5. More than 40 different alternatively spliced transcript variants have been isolated from both tumor and normal tissues.
E3 ubiquitin-protein ligase Mdm2
, Mdm2, p53 E3 ubiquitin protein ligase homolog
, Mdm2, transformed 3T3 cell double minute 2, p53 binding protein
, double minute 2, human homolog of; p53-binding protein
, oncoprotein Mdm2
, double minute 2 protein
, p53-binding protein Mdm2